Citations (73)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (17)
Hinata Ueda, Katsuya Narumi, Shuho Asano, Yoshitaka Saito, Ayako Furugen & Masaki Kobayashi. (2024) Comparative study on the occurrence of adverse effects in the concomitant use of azathioprine and aldehyde oxidase inhibitors. Expert Opinion on Drug Safety 23:1, pages 89-97.
Read now
Read now
Francesca Toselli, Melanie Golding, Johan Nicolaï, Eric Gillent & Hugues Chanteux. (2022) Drug clearance by aldehyde oxidase: can we avoid clinical failure?. Xenobiotica 52:8, pages 890-903.
Read now
Read now
Narges Cheshmazar, Siavoush Dastmalchi, Mineko Terao, Enrico Garattini & Maryam Hamzeh-Mivehroud. (2019) Aldehyde oxidase at the crossroad of metabolism and preclinical screening. Drug Metabolism Reviews 51:4, pages 428-452.
Read now
Read now
Samaneh Soleymani, Roodabeh Bahramsoltani, Roja Rahimi & Mohammad Abdollahi. (2017) Clinical risks of St John’s Wort (Hypericum perforatum) co-administration. Expert Opinion on Drug Metabolism & Toxicology 13:10, pages 1047-1062.
Read now
Read now
Tomoyuki Isobe, Masayuki Ohta, Yoshio Kaneko & Hiroyuki Kawai. (2016) Species differences in metabolism of ripasudil (K-115) are attributed to aldehyde oxidase. Xenobiotica 46:7, pages 579-590.
Read now
Read now
Swati Jaiswal, Abhisheak Sharma, Mahendra Shukla, Kalpesh Vaghasiya, Nagarjun Rangaraj & Jawahar Lal. (2014) Novel pre-clinical methodologies for pharmacokinetic drug–drug interaction studies: spotlight on “humanized” animal models. Drug Metabolism Reviews 46:4, pages 475-493.
Read now
Read now
Ramakrishna Nirogi, Vishwottam Kandikere, Raghava Choudary Palacharla, Gopinadh Bhyrapuneni, Vijaya Bhargava Kanamarlapudi, Ranjith Kumar Ponnamaneni & Arun Kumar Manoharan. (2014) Identification of a suitable and selective inhibitor towards aldehyde oxidase catalyzed reactions. Xenobiotica 44:3, pages 197-204.
Read now
Read now
Shigeyuki Kitamura & Kazumi Sugihara. (2014) Current status of prediction of drug disposition and toxicity in humans using chimeric mice with humanized liver. Xenobiotica 44:2, pages 123-134.
Read now
Read now
Chiaki Tanoue, Kazumi Sugihara, Naoto Uramaru, Yoshitaka Tayama, Yoko Watanabe, Toru Horie, Shigeru Ohta & Shigeyuki Kitamura. (2013) Prediction of human metabolism of the sedative-hypnotic zaleplon using chimeric mice transplanted with human hepatocytes. Xenobiotica 43:11, pages 956-962.
Read now
Read now
Maryam Hamzeh-Mivehroud, Seifullah Rahmani, Mohammad-Reza Rashidi, Mohammad-Ali Hosseinpour Feizi & Siavoush Dastmalchi. (2013) Structure-based investigation of rat aldehyde oxidase inhibition by flavonoids. Xenobiotica 43:8, pages 661-670.
Read now
Read now
Brian G. Lake & Roger J. Price. (2013) Evaluation of the metabolism and hepatotoxicity of xenobiotics utilizing precision-cut slices. Xenobiotica 43:1, pages 41-53.
Read now
Read now
Saeed Pirouzpanah, Jalal Hanaee, Seyed-Vali Razavieh & Mohammad-Reza Rashidi. (2009) Inhibitory effects of flavonoids on aldehyde oxidase activity. Journal of Enzyme Inhibition and Medicinal Chemistry 24:1, pages 14-21.
Read now
Read now
Inge AM de Graaf, Geny MM Groothuis & Peter Olinga. (2007) Precision-cut tissue slices as a tool to predict metabolism of novel drugs. Expert Opinion on Drug Metabolism & Toxicology 3:6, pages 879-898.
Read now
Read now
A. Madan, A. Fisher, L. Jin, D. Chapman & H. P. Bozigian. (2007) metabolism of indiplon and an assessment of its drug interaction potential. Xenobiotica 37:7, pages 736-752.
Read now
Read now
Margherita Strolin Benedetti, Rhys Whomsley & Eugène Baltes. (2006) Involvement of enzymes other than CYPs in the oxidative metabolism of xenobiotics. Expert Opinion on Drug Metabolism & Toxicology 2:6, pages 895-921.
Read now
Read now
Nagwa
H. Foda, A. Abd Elbary & O. El‐Gazayerly. (2006) Reversed–Phase Liquid Chromatographic Determination of Zaleplon in Human Plasma and its Pharmacokinetic Application. Analytical Letters 39:9, pages 1891-1905.
Read now
Read now
A. B. Renwick, S. E. Ball, J. M. Tredger, R. J. Price, D. G. Walters, J. Kao, J. A. Scatina & B. G. Lake. (2002) Inhibition of zaleplon metabolism by cimetidine in the human liver: in vitro studies with subcellular fractions and precision-cut liver slices. Xenobiotica 32:10, pages 849-862.
Read now
Read now
Articles from other publishers (56)
Stephen W. Wright. (2023) Synthesis of Deuterated Enaminones with High Isotopic Fidelity. ACS Medicinal Chemistry Letters 14:12, pages 1742-1745.
Crossref
Crossref
Nihan Izat, Jayaprakasam Bolleddula, Armina Abbasi, Lionel Cheruzel, Robert S. Jones, Darren Moss, Fatima Ortega-Muro, Yannick Parmentier, Vincent C. Peterkin, Dan-Dan Tian, Karthik Venkatakrishnan, Michael A. Zientek, Jill Barber, J. Brian Houston, Aleksandra Galetin & Daniel Scotcher. (2023) Challenges and Opportunities for In Vitro–In Vivo Extrapolation of Aldehyde Oxidase-Mediated Clearance: Toward a Roadmap for Quantitative Translation. Drug Metabolism and Disposition 51:12, pages 1591-1606.
Crossref
Crossref
Anam Hammid, John K. Fallon, Kati-Sisko Vellonen, Toni Lassila, Mika Reinisalo, Arto Urtti, Francisco Gonzalez, Ari Tolonen, Philip C. Smith & Paavo Honkakoski. (2023) Aldehyde oxidase 1 activity and protein expression in human, rabbit, and pig ocular tissues. European Journal of Pharmaceutical Sciences 191, pages 106603.
Crossref
Crossref
Julia M. Smyk & Anna Majewska. (2022) Favipiravir in the Battle with Respiratory Viruses. Mini-Reviews in Medicinal Chemistry 22:17, pages 2224-2236.
Crossref
Crossref
Slobodan P. Rendić, Rachel D. Crouch & F. Peter Guengerich. (2022) Roles of selected non-P450 human oxidoreductase enzymes in protective and toxic effects of chemicals: review and compilation of reactions. Archives of Toxicology 96:8, pages 2145-2246.
Crossref
Crossref
Xiaoyan Pang, Chongzhuang Tang, Runcong Guo & Xiaoyan Chen. (2022) Non-cytochrome P450 enzymes involved in the oxidative metabolism of xenobiotics: Focus on the regulation of gene expression and enzyme activity. Pharmacology & Therapeutics 233, pages 108020.
Crossref
Crossref
Chulho Choi, Anthony A. Carlo, Ciarán N. Cronin, Konghua Jing, Daniel W. Kung, Jianhua Liu, Vincent M. Lombardo, Abigail R. Turco, Juxing Yin, Aijia Yu & Stephen W. Wright. (2022)
Synthesis of Deuterated Heterocycles with Me
2
NCD(OMe)
2
and Evaluation of the Products for Metabolism by Aldehyde Oxidase
. ACS Medicinal Chemistry Letters 13:2, pages 250-256.
Crossref
Crossref
Gianluca Catucci, Gianfranco Gilardi & Sheila J. Sadeghi. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
509
562
.
Ciarán N. Cronin, JianHua Liu, Nicole Grable, Timothy J. Strelevitz, R. Scott Obach & Anthony Carlo. (2021) Production of active recombinant human aldehyde oxidase (AOX) in the baculovirus expression vector system (BEVS) and deployment in a pre-clinical fraction-of-control AOX compound exposure assay. Protein Expression and Purification 177, pages 105749.
Crossref
Crossref
Erickson M. Paragas, Kanika Choughule, Jeffrey P. Jones & John T. Barr. 2021. Enzyme Kinetics in Drug Metabolism. Enzyme Kinetics in Drug Metabolism
257
284
.
Mailys De Sousa Mendes, Alexandra L. Orton, Helen E. Humphries, Barry Jones, Iain Gardner, Sibylle Neuhoff & Venkatesh Pilla Reddy. (2020) A Laboratory-Specific Scaling Factor to Predict the In Vivo Human Clearance of Aldehyde Oxidase Substrates. Drug Metabolism and Disposition 48:11, pages 1231-1238.
Crossref
Crossref
Wee Kiat Tan, Alyssa Rui Yi Tan, Punitha Sivanandam, Ernest Jing Hui Goh, Ze Ping Yap, Nur Fazilah Saburulla, Karl Austin-Muttitt, Jonathan G.L. Mullins & Aik Jiang Lau. (2020) In Vitro Inhibition of Human Aldehyde Oxidase Activity by Clinically Relevant Concentrations of Gefitinib and Erlotinib: Comparison with Select Metabolites, Molecular Docking Analysis, and Impact on Hepatic Metabolism of Zaleplon and Methotrexate. Journal of Pharmacology and Experimental Therapeutics 374:2, pages 295-307.
Crossref
Crossref
Yin‐Xiao Du & Xiao‐Ping Chen. (2020) Favipiravir: Pharmacokinetics and Concerns About Clinical Trials for 2019‐nCoV Infection. Clinical Pharmacology & Therapeutics 108:2, pages 242-247.
Crossref
Crossref
Yixue Qiao, Kaushik Maiti, Zakia Sultana, Lei Fu & Roger Smith. (2020) Inhibition of vertebrate aldehyde oxidase as a therapeutic treatment for cancer, obesity, aging and amyotrophic lateral sclerosis. European Journal of Medicinal Chemistry 187, pages 111948.
Crossref
Crossref
Nenad Manevski, Lloyd King, William R. Pitt, Fabien Lecomte & Francesca Toselli. (2019) Metabolism by Aldehyde Oxidase: Drug Design and Complementary Approaches to Challenges in Drug Discovery. Journal of Medicinal Chemistry 62:24, pages 10955-10994.
Crossref
Crossref
Deepak Dalvie & Li Di. (2019) Aldehyde oxidase and its role as a drug metabolizing enzyme. Pharmacology & Therapeutics 201, pages 137-180.
Crossref
Crossref
Haruka Nishimuta, Takao Watanabe & Kiyoko Bando. (2019) Quantitative Prediction of Human Hepatic Clearance for P450 and Non-P450 Substrates from In Vivo Monkey Pharmacokinetics Study and In Vitro Metabolic Stability Tests Using Hepatocytes. The AAPS Journal 21:2.
Crossref
Crossref
Takuo Ogiso, Tatsuki Fukami, Kenji Mishiro, Keigo Konishi, Jeffrey P. Jones & Miki Nakajima. (2018) Substrate selectivity of human aldehyde oxidase 1 in reduction of nitroaromatic drugs. Archives of Biochemistry and Biophysics 659, pages 85-92.
Crossref
Crossref
Cristiano Mota, Catarina Coelho, Silke Leimkühler, Enrico Garattini, Mineko Terao, Teresa Santos-Silva & Maria João Romão. (2018) Critical overview on the structure and metabolism of human aldehyde oxidase and its role in pharmacokinetics. Coordination Chemistry Reviews 368, pages 35-59.
Crossref
Crossref
Takayuki Amano, Tatsuki Fukami, Takuo Ogiso, Daisuke Hirose, Jeffrey P. Jones, Tsuyoshi Taniguchi & Miki Nakajima. (2018) Identification of enzymes responsible for dantrolene metabolism in the human liver: A clue to uncover the cause of liver injury. Biochemical Pharmacology 151, pages 69-78.
Crossref
Crossref
Gökhan Kücükgöze & Silke Leimkühler. (2018) Direct comparison of the four aldehyde oxidase enzymes present in mouse gives insight into their substrate specificities. PLOS ONE 13:1, pages e0191819.
Crossref
Crossref
David J. Wilkinson, Rosalind L. Southall, Mingguang Li, Lisa M. Wright, Lindsay J. Corfield, Thomas A. Heeley, Benjamin Bratby, Ranbir Mannu, Sarah L. Johnson, Victoria Shaw, Holly L. Friett, Louise A. Blakeburn, John S. Kendrick & Michael B. Otteneder. (2017) Minipig and Human Metabolism of Aldehyde Oxidase Substrates: In Vitro–In Vivo Comparisons. The AAPS Journal 19:4, pages 1163-1174.
Crossref
Crossref
Paula K. Schweitzer & Stephen D. Feren. 2017. Clinical Handbook of Insomnia. Clinical Handbook of Insomnia
97
132
.
M. A. Cerny. (2016) Prevalence of Non-Cytochrome P450-Mediated Metabolism in Food and Drug Administration-Approved Oral and Intravenous Drugs: 2006-2015. Drug Metabolism and Disposition 44:8, pages 1246-1252.
Crossref
Crossref
Philip M. Becker & Manya Somiah. (2015) Non–Benzodiazepine Receptor Agonists for Insomnia. Sleep Medicine Clinics 10:1, pages 57-76.
Crossref
Crossref
Seigo Sanoh, Yoshitaka Tayama, Kazumi Sugihara, Shigeyuki Kitamura & Shigeru Ohta. (2015) Significance of aldehyde oxidase during drug development: Effects on drug metabolism, pharmacokinetics, toxicity, and efficacy. Drug Metabolism and Pharmacokinetics 30:1, pages 52-63.
Crossref
Crossref
Seigo Sanoh & Shigeru Ohta. (2013) Chimeric mice transplanted with human hepatocytes as a model for prediction of human drug metabolism and pharmacokinetics. Biopharmaceutics & Drug Disposition 35:2, pages 71-86.
Crossref
Crossref
Domenic A. Ciraulo & Mark Oldham. 2014. The Effects of Drug Abuse on the Human Nervous System. The Effects of Drug Abuse on the Human Nervous System
499
532
.
John T. Barr, Kanika Choughule & Jeffrey P. Jones. 2014. Enzyme Kinetics in Drug Metabolism. Enzyme Kinetics in Drug Metabolism
167
186
.
Chiaki Tanoue, Kazumi Sugihara, Naoto Uramaru, Yoko Watanabe, Yoshitaka Tayama, Shigeru Ohta & Shigeyuki Kitamura. (2013) Strain Difference of Oxidative Metabolism of the Sedative-hypnotic Zaleplon by Aldehyde Oxidase and Cytochrome P450 In Vivo and In Vitro in Rats. Drug Metabolism and Pharmacokinetics 28:3, pages 269-273.
Crossref
Crossref
Ryan D. Morrison, Anna L. Blobaum, Frank W. Byers, Tammy S. Santomango, Thomas M. Bridges, Donald Stec, Katrina A. Brewer, Raymundo Sanchez-Ponce, Melany M. Corlew, Roger Rush, Andrew S. Felts, Jason Manka, Brittney S. Bates, Daryl F. Venable, Alice L. Rodriguez, Carrie K. Jones, Colleen M. Niswender, P. Jeffrey Conn, Craig W. Lindsley, Kyle A. Emmitte & J. Scott Daniels. (2012) The Role of Aldehyde Oxidase and Xanthine Oxidase in the Biotransformation of a Novel Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5. Drug Metabolism and Disposition 40:9, pages 1834-1845.
Crossref
Crossref
Timothy J. Strelevitz, Christine C. Orozco & R. Scott Obach. (2012) Hydralazine As a Selective Probe Inactivator of Aldehyde Oxidase in Human Hepatocytes: Estimation of the Contribution of Aldehyde Oxidase to Metabolic Clearance. Drug Metabolism and Disposition 40:7, pages 1441-1448.
Crossref
Crossref
Alexander V. LyubimovMichael Zientek, Ping Kang, Matthew J. Hutzler & Scott R. Obach. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
59
.
Chun Li & Nataraj Kalyanaraman. 2012. ADME‐Enabling Technologies in Drug Design and Development. ADME‐Enabling Technologies in Drug Design and Development
189
212
.
. 2012. Pharmacokinetics and Metabolism in Drug Design. Pharmacokinetics and Metabolism in Drug Design
111
158
.
Lin Xu, Caroline Woodward, Samina Khan & Chandra Prakash. (2012) In Vitro Metabolism of BIIB021, an Inhibitor of Heat Shock Protein 90, in Liver Microsomes and Hepatocytes of Rats, Dogs, and Humans and Recombinant Human Cytochrome P450 Isoforms. Drug Metabolism and Disposition 40:4, pages 680-693.
Crossref
Crossref
J. Matthew Hutzler, Young-Sun Yang, Daniel Albaugh, Cody L. Fullenwider, Jennifer Schmenk & Michael B. Fisher. (2012) Characterization of Aldehyde Oxidase Enzyme Activity in Cryopreserved Human Hepatocytes. Drug Metabolism and Disposition 40:2, pages 267-275.
Crossref
Crossref
Seigo Sanoh, Kazuyoshi Nozaki, Hidetsugu Murai, Shigeyuki Terashita, Toshio Teramura & Shigeru Ohta. (2012) Prediction of Human Metabolism of FK3453 by Aldehyde Oxidase Using Chimeric Mice Transplanted with Human or Rat Hepatocytes. Drug Metabolism and Disposition 40:1, pages 76-82.
Crossref
Crossref
John T. Barr & Jeffrey P. Jones. (2011) Inhibition of Human Liver Aldehyde Oxidase: Implications for Potential Drug-Drug Interactions. Drug Metabolism and Disposition 39:12, pages 2381-2386.
Crossref
Crossref
David C. Pryde, Deepak Dalvie, Qiyue Hu, Peter Jones, R. Scott Obach & Thien-Duc Tran. (2010) Aldehyde Oxidase: An Enzyme of Emerging Importance in Drug Discovery. Journal of Medicinal Chemistry 53:24, pages 8441-8460.
Crossref
Crossref
Andrew Parkinson, Brian W. Ogilvie, Brandy L. Paris, Tiffini N. Hensley & Greg J. Loewen. 2010. Biotransformation and Metabolite Elucidation of Xenobiotics. Biotransformation and Metabolite Elucidation of Xenobiotics
1
77
.
Michael Zientek, Ying Jiang, Kuresh Youdim & R. Scott Obach. (2010) In Vitro-In Vivo Correlation for Intrinsic Clearance for Drugs Metabolized by Human Aldehyde Oxidase. Drug Metabolism and Disposition 38:8, pages 1322-1327.
Crossref
Crossref
Ikuo Yamamiya, Kunihiro Yoshisue, Eiji Matsushima & Sekio Nagayama. (2010) Formation Pathways of γ-Butyrolactone from the Furan Ring of Tegafur during Its Conversion to 5-Fluorouracil. Drug Metabolism and Disposition 38:8, pages 1267-1276.
Crossref
Crossref
Deepak Dalvie, Chenghong Zhang, Weichao Chen, Teresa Smolarek, R. Scott Obach & Cho-Ming Loi. (2010) Cross-Species Comparison of the Metabolism and Excretion of Zoniporide: Contribution of Aldehyde Oxidase to Interspecies Differences. Drug Metabolism and Disposition 38:4, pages 641-654.
Crossref
Crossref
Johannes M. Dieterich, Hans-Joachim Werner, Ricardo A. Mata, Sebastian Metz & Walter Thiel. (2010)
Reductive half-reaction of aldehyde oxidoreductase toward acetaldehyde:
Ab initio
and free energy quantum mechanical/molecular mechanical calculations
. The Journal of Chemical Physics 132:3.
Crossref
Crossref
Enrico Garattini, Maddalena Fratelli & Mineko Terao. (2009) The mammalian aldehyde oxidase gene family. Human Genomics 4:2.
Crossref
Crossref
Andrew D. Krystal. (2009) A compendium of placebo-controlled trials of the risks/benefits of pharmacological treatments for insomnia: The empirical basis for U.S. clinical practice. Sleep Medicine Reviews 13:4, pages 265-274.
Crossref
Crossref
Chandra Prakash & Alfin D. N. Vaz. 2008. Nuclear Receptors in Drug Metabolism. Nuclear Receptors in Drug Metabolism
1
41
.
Mohammad-Hossein Sorouraddin, Ebrahim Fooladi, Abdolhossein Naseri & Mohammad-Reza Rashidi. (2008) A novel spectrophotometric method for determination of kinetic constants of aldehyde oxidase using multivariate calibration method. Journal of Biochemical and Biophysical Methods 70:6, pages 999-1005.
Crossref
Crossref
Christian Dolder, Michael Nelson & Jonathan McKinsey. (2007) Use of Non-Benzodiazepine Hypnotics in the Elderly. CNS Drugs 21:5, pages 389-405.
Crossref
Crossref
Fazlul Huq. (2006) Molecular Modelling Analysis of the Metabolism of Zaleplon. Journal of Pharmacology and Toxicology 1:4, pages 328-336.
Crossref
Crossref
Beibei Zhang, Zunjian Zhang, Yuan Tian, Fengguo Xu & Yun Chen. (2006) High-performance liquid chromatography–atmospheric pressure chemical ionisation-mass spectrometry determination of zaleplon in human plasma. Journal of Pharmaceutical and Biomedical Analysis 40:3, pages 707-714.
Crossref
Crossref
Lawrence W. Anderson, Jerry M. Collins, Raymond W. Klecker, Aspandiar G. Katki, Ralph E. Parchment, Ramesh R. Boinpally, Patricia M. LoRusso & S. Percy Ivy. (2005) Metabolic profile of XK469 (2(R)-[4-(7-chloro-2-quinoxalinyl)oxyphenoxy]-propionic acid; NSC698215) in patients and in vitro: low potential for active or toxic metabolites or for drug–drug interactions. Cancer Chemotherapy and Pharmacology 56:4, pages 351-357.
Crossref
Crossref
Mami Kurosaki, Mineko Terao, Maria Monica Barzago, Antonio Bastone, Davide Bernardinello, Mario Salmona & Enrico Garattini. (2004) The Aldehyde Oxidase Gene Cluster in Mice and Rats. Journal of Biological Chemistry 279:48, pages 50482-50498.
Crossref
Crossref
R. Scott Obach, Phuong Huynh, Mary C. Allen & Christine Beedham. (2013) Human Liver Aldehyde Oxidase: Inhibition by 239 Drugs. The Journal of Clinical Pharmacology 44:1, pages 7-19.
Crossref
Crossref
R. Scott Obach. (2004) POTENT INHIBITION OF HUMAN LIVER ALDEHYDE OXIDASE BY RALOXIFENE. Drug Metabolism and Disposition 32:1, pages 89-97.
Crossref
Crossref